Literature DB >> 7538031

Granulocyte colony stimulating factor treatment for neonatal neutropenia.

A R Russell1, E G Davies, S E Ball, E Gordon-Smith.   

Abstract

In a pilot study recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered to 12 neutropenic preterm infants to determine if neonatal neutropenia is secondary to decreased endogenous G-CSF production. Respiratory variables were monitored because of the possible link between inflammatory cells and hyaline membrane disease. All infants showed increased neutrophil counts. The only possible side effect observed was an exacerbation of thrombocytopenia.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7538031      PMCID： PMC2528420          DOI： 10.1136/fn.72.1.f53

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


  5 in total

1.  Therapeutic implications of dysregulated colony-stimulating factor expression in neonates.

Authors:  M S Cairo
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

2.  Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.

Authors:  R L Roberts; C M Szelc; S M Scates; M T Boyd; K M Soderstrom; M W Davis; J A Glaspy
Journal:  Am J Dis Child       Date:  1991-07

3.  Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns.

Authors:  R L Rodwell; K M Taylor; D I Tudehope; P H Gray
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

4.  Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.

Authors:  P B Hansen; H E Johnsen; E Ralfkiaer; N E Hansen
Journal:  Br J Haematol       Date:  1993-08       Impact factor: 6.998

5.  Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance.

Authors:  B E Ogden; S A Murphy; G C Saunders; D Pathak; J D Johnson
Journal:  Am Rev Respir Dis       Date:  1984-11
  5 in total
  7 in total

Review 1.  Promising stratagems for reducing the burden of neonatal sepsis.

Authors:  N Modi; R Carr
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

Review 2.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.

Authors:  A R Bedford Russell; A J Emmerson; N Wilkinson; T Chant; D G Sweet; H L Halliday; B Holland; E G Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 4.  Haemopoietic colony stimulating factors for preterm neonates.

Authors:  R Carr; N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

Review 5.  New modalities for treating neonatal infection.

Authors:  A R Bedford-Russell
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

6.  Recombinant haemopoietic growth factors in the newborn--will they be useful?

Authors:  C A Wardrop; B M Holland
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

7.  Late-onset neutropenia: defining limits of neutrophil count in very low birth weight infants.

Authors:  S Vetter-Laracy; P-R Balliu; J A Salinas; M A Duran
Journal:  J Perinatol       Date:  2013-09-12       Impact factor: 2.521
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.